February 8, 2018
February 8, 2018
Cronos Group News
Please Note: Press releases contained on this website are for historical purposes only and that while information contained within the releases was believed to be accurate at the time of issue, the Company will not, and specifically disclaims any duty to, update this information.
Cronos Group Inc. is pleased to announce that it has entered into a letter of engagement with PI Financial Corp. as lead underwriter on behalf of a syndicate of underwriters under which the Underwriters have agreed to purchase for re-sale 3,428,572 common shares of the Company.read more
TORONTO, ON (December 27, 2017) – Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int’l Designation: PRMCF) (“Cronos” or the “Company”) is pleased to announce that its first shipment to G. Pohl-Boskamp GmbH & Co. KG (“Pohl-Boskamp”) of Peace Naturals (“Peace”) branded...read more
Cronos Group today reported financial results for the third quarter ended September 30, 2017. Financial results and the management discussion and analysis are available on the Company’s website and SEDAR (www.sedar.com).read more
Cronos Group will release its financial results for the third quarter ended September 30, 2017 before the market opens on November 29, 2017read more
Cronos is pleased to announce that its previously announced strategic joint venture with Kibbutz Gan Shmuel for the production, manufacture, and global distribution of medical cannabis, has been approved by the TSX Venture Exchange.read more
Unaudited Consolidated Financial reports and Management’s Discussion and Analysis reports for Cronos Group will be posted here quarterly. Please visit SEDAR for a complete listing of corporate filings and archived filings for Cronos Group Inc.
720 King Street West., Suite 320
Toronto, Ontario M5V 2T3